Litigation Details for United States v. Gilead Sciences, Inc. (D. Del. 2019)
✉ Email this page to a colleague
United States v. Gilead Sciences, Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-11-06 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | Plaintiff | Referred To | |
Patents | 10,029,015; 6,031,003; 6,031,007; 6,043,230; 6,703,396; 7,390,791; 7,803,788; 8,013,002; 8,754,065; 9,056,051; 9,056,052; 9,296,769 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United States v. Gilead Sciences, Inc.
Biologic Drugs cited in United States v. Gilead Sciences, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for United States v. Gilead Sciences, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-12-05 | 370 | Exhibit REDACTED Ex A-Z | .S. Patent No. 7,803,788 lists “Gilead Sciences, Inc.” as the assignee. Claim 7 of this patent recites…509 Patent, the ’333 Patent, the ’191 Patent, and the ’423 Patent (collectively, the “Patents-in-Suit… 13 of the ‘509 Patent, claim 13 of the ‘333 Patent, claim 13 of the ’191 Patent, and claim 12 of the…claim 13 of the ’509 Patent, claim 13 of the ’333 Patent, claim 13 of the ’191 Patent, and claim 12 of …from the different patents: ’509 Patent ’333 Patent | External link to document |
2023-04-03 | 422 | Exhibit A-I | 5,914,331; 5,922,695; 5,935,946; 5,977,089; 6,043,230; 6,057,305; 6,703,396; 7,390,791; 7,803,788…obviousness-type double patenting rejections for the ’333 Patent, the ’191 Patent, and the ’423 Patent, but was … of the ’191 Patent, the ’333 Patent, and the ’423 Patent, the claims of all Patents-in-Suit are …States Patent and Trademark Office. 20. “Patent(s)-in-Suit” refers to U.S. Patent Nos. 9,044,509…license to a patent allegedly comparable to the Patents-in-Suit and any license to a patent relating | External link to document |
2023-04-03 | 425 | Exhibit Nos. 51-58 | situations where 15:06:31 3 sexual intercourse occurs, although, of …Q And your patent -- you later assigned your 13:55:48 11 patents to the U.S. government… G. MAJORS, Administrative Patent Judges. YANG, Administrative Patent Judge. … IPR2019-01454 Patent 9,579,333 B2 In this case, as Patent Owner correctly points …during the prosecution of the ’333 patent and the parent U.S. Patent No. 9,044,509 B2 (Ex. 1003, (65 | External link to document |
2023-05-31 | 485 | - Transcript | two extended safety of Tenofovir Disoproxil 10:29:0015 Fumarate (TDF) among HIV-1 negative men who…prosecution of the 09:39:3224 '333 patent and subsequent patents? 09:39:3425 A. Yes. Case 1…here because the patent, the government 09:52:0911 scientists who filed this patent, they weren'…is a patent agent of the law firm Klarquist Sparkman, 09:57:44 4 LLP, who prosecuted the patents-in-…application that resulted in the '509 patent was 09:25:07 4 U.S. Patent Application No. 11/669547, correct | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |